Even in an off-quarter, biotech showed itself to be a key driver of New York's growing tech sector, and that momentum will need to continue in the face of stiff market headwinds. Venture-capital investment in medical and biotech startups dipped slightly in the first quarter of the year, according to a report from PricewaterhouseCoopers/National Venture Capital Association, with data from Thomson Reuters.
image: http://www.freedigitalphotos.net
